OmniAb Unveils Latest Scientific Data on OmnidAb™ Platform at 2023 Antibody Engineering Conference

OmniAb, Inc.  announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...

December 15, 2023 | Friday | News
Novozymes and Chr. Hansen Unveil Unified Identity: Novonesis, Marking a Powerful Synergy in the Biotech Industry

Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...

December 13, 2023 | Wednesday | News
South Korean Genomics Giant, Macrogen, Secures Strong Presence in Basel, Switzerland

  Macrogen Europe is seeking to expand within Switzerland from its foothold in Basel with its Sanger sequencing laborato...

December 13, 2023 | Wednesday | News
Freya Biosciences Raises $38M in Significant Series A for Women’s Reproductive Immunotherapies

Series A led by Sofinnova Partners and OMX Ventures Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announced today a ...

December 12, 2023 | Tuesday | News
SkylineDx and VIB Initiate Joint Research Program on Immune Prediction

The significant milestone marks the first result of the company's strategic partnership2 with VIB, Flanders' leading life sciences institute, and potential...

December 11, 2023 | Monday | News
Merck Partners with Acceleration Consortium for AI-Driven Experimentation Open Source

Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-d...

December 11, 2023 | Monday | News
IMIDomics and Bristol Myers Squibb Extend Partnership for Inflammatory Disease Research

In 2016, IMIDomics entered into a strategic partnership with BMS to harness their unique clinical and molecular database, and multidimensional analysis con...

December 07, 2023 | Thursday | News
Sanofi's Pipeline Transformation for Immunology Leadership Through Record Potential Blockbusters

Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with ...

December 07, 2023 | Thursday | News
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, O...

December 04, 2023 | Monday | News
Merck Acquires Caraway Therapeutics as Dementia Discovery Fund Facilitates Groundbreaking Move

The Dementia Discovery Fund (DDF), a SV Health Investors (SV) fund specialized in pursuing transformational therapeutic approaches for dementias including ...

November 23, 2023 | Thursday | News
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell an...

November 20, 2023 | Monday | News
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer

Serina Therapeutics, Inc. (Serina), a privately held, clinical stage biotechnology company focused on developing its proprietary POZ Platform TMdrug delive...

November 20, 2023 | Monday | News
Cytiva Introduces Groundbreaking Affinity Technology for Versatile Protein Purification

Cytiva, a global leader in life sciences, introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant pro...

November 17, 2023 | Friday | News
Repligen CEO Tony Hunt Highlights ESG Success in 2022 Progress Report

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its ...

November 15, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close